Navigation Links
Genome of barley disease reveals surprises
Date:12/10/2010

Scientists have sequenced the genome of a major fungal disease that affects barley and other cereal crops, a breakthrough that could lead to significant advances in our understanding of how plant diseases evolve. The research, published today in the journal Science, suggests that parasites within the genome of the fungus help the disease to adapt and overcome the plant's defences.

The study could help with the development of new agricultural techniques for protecting cereal crops from infection. Barley grains are the basis of many staple foods, and also central to the brewing and malting industries, so keeping the plants disease-free is becoming increasingly important for food security. Today's research, led by Dr Pietro Spanu from the Department of Life Sciences at Imperial College London, decodes the genome of Blumeria, which causes powdery mildew on barley.

Powdery mildew affects a wide range of fruit, vegetable and cereal crops in northern Europe. Infected plants become covered in powdery white spots that spread all over the leaves and stems, preventing them from producing crops, and having a devastating impact on the overall agricultural yield. Farmers use fungicides, genetically resistant varieties and crop rotation to prevent mildew epidemics, but the fungi often evolve too rapidly for the techniques to be effective. The mildew is able to evolve so quickly because multiple parasites within the genome, known as 'transposons', help it to disguise itself and go unrecognised by the plant's defences. It is as if the transposons confuse the host plant by changing the target molecules that the plant uses to detect the onset of disease.

The researchers discovered that Blumeria had unusually large numbers of transposons within it. "It was a big surprise," said Dr Spanu, "as a genome normally tries to keep its transposons under control. But in these genomes, one of the controls has been lifted. We think it might be an adaptive advantage for them to have these genomic parasites, as it allows the pathogens to respond more rapidly to the plant's evolution and defeat the immune system."

The authors believe that their research will contribute significantly to the design of new fungicides and resistance in food crops, as they now understand how the mildew can adapt so quickly. "With this knowledge of the genome we can now rapidly identify which genes have mutated, and then can select plant varieties that are more resistant," said Dr Spanu. The genetic codes will also help scientists monitor the spread and evolution of fungicide resistance in an emerging epidemic. "We'll be able to develop more efficient ways to monitor and understand the emergence of resistance, and ultimately to design more effective and durable control measures."

Mildew pathogens are a type of 'obligate' parasite, which means they are completely dependent on their plant hosts to survive, and cannot live freely in the soil. Because they are so dependent, the pathogens have devised a way to disguise themselves in order to avoid the immune response of the host plant and overcome its defences.

"We've now found this happening in lots of fungi and fungal-like organisms that are obligate pathogens," said Dr Spanu, adding that the costly genome inflation could therefore be a trade-off that makes these pathogens successful. "Non-obligate pathogens are not so dependent on their hosts, as they can live elsewhere," said Dr Spanu, "so they are less dependent on rapid evolution."


'/>"/>

Contact: Laura Gallagher
l.gallagher@imperial.ac.uk
44-020-759-48432
Imperial College London
Source:Eurekalert

Related biology news :

1. Scientists propose new international cancer effort akin to Human Genome Project
2. Genome 10K Project announces first 101 species for genome sequencing
3. MU plant genome research receives $3 million boost from National Science Foundation
4. ASPB members lead new plant genome research program awards
5. Is the shape of a genome as important as its content?
6. NSF awards new projects for plant genome research
7. NSF awards $3.75 million grant to New York Plant Genome Consortium for the creation of BigPlant v1.0
8. NIH-funded scientists sequence genomes of lyme disease bacteria
9. Singapore scientists first to perform genome-wide study of human stem cells
10. UBC gains $5.4 million for microbiome research from CIHR, Genome BC
11. UF to help sequence genome of flowering plants ancient living relative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology: